What’s cooking in the IPO kitchen?
Eco (Atlantic) Oil & Gas—TSX-V listed oil and gas exploration yesterday announced its intention to float on AIM. Assets in Guyana and Namibia. Proposed £2m-£3m fundraise.
Diversified Gas & Oil—According to LSE website first day of trading on AIM now expected for 30 January.
Sareum Holdings* (LON:SAR) 0.93p £24.5m
The specialist cancer drug discovery and development company, has announced the attainment of a US$2m success milestone payment as part of the Chk1 licence agreement between its co-investment partner, the CRT Pioneer Fund, and Sierra Oncology, Inc. (NASDAQ: SRRA), formerly, until yesterday, ProNAi Therapeutics, Inc. Further payments up to US$319.5m may become payable upon achievement of certain milestones plus high single to low double digit royalties on the net sales of any product successfully developed. Sareum is entitled to 27.5% of all payments arising from the Chk1 licence agreement. Therefore, Sareum will receive $550k as its financial share of this milestone event. Furthermore, the unspent balance, now estimated at c£200k of the financial commitment to the trial funding will be returned to Sareum in due course.
ABCAM (LON:ABC) 901p £1.6bm
HY Dec16 trading update from the supplier of life science research tools. Expects revenue growth of 10.0% on a constant currency basis and 30.4% on a reported basis. Remains on track to deliver its revenue expectations for the full year. “Catalogue revenue grew by 10.7% in the first half of the year. Growth from primary antibodies continues to outpace market growth rates, largely driven by RabMAb® product revenue, which grew by 26.6% (ahead of our full year 2016/17 guidance of 18-22%). Non-primary antibody product revenues grew by 15.7%, which is lower than our full year guidance of 20-25% due to one-time large volume orders that have not been repeated in this half year.” FYJun17E rev of £206.6m, PBT £56.16m, EPS 24.1p, Div, 9.65p.
Trading update: The current financial year has started strongly with a significant rise in student numbers year on year and with a corresponding significant increase in turnover. Implementation of the new IT system which will facilitate considerable expansion of student numbers across multiple brands is proceeding satisfactorily and in accordance with the planned timetable. FY Aug17E rev of £2.6m and £0.1m PBT.
Deferred Consideration: In accordance with the earn-out agreement Wey has paid the vendor £101.7k in cash and2.6m shares locked in for one year. The vendors now have a 13.3% stake in Wey.
H&T Group (LON:HAT) 300.5p £98.17m
Trading update from the UK’s leading pawnbroker. The Board expects full year profit before tax to be marginally ahead of current market expectations. During the year the Group has made significant progress in the development of its business model with strong growth in Personal Loans, Buyback and FX. The increase in the sterling gold price since the EU referendum result has also increased profits from both the Pawnbroking Scrap and Gold Purchasing segments. FYDEC16E revs of £91.78m, PBT £9.03m, EPS 19.59p, Div 8.83p. PE of 12.5x, 3.4% yield.
The cinema Group has updated on trading for FYDec16. Trading above market expectations. A combination of factors have contributed to these results including the better than anticipated performance of some new venues and continued improvements in existing locations. 2016 saw the six new venues and two refurbishment projects from 2015 start to mature, and in addition the Company opened four new venues. FYDec16E revs of £28.8m and PBY of £0.79m.
The investment manager focused on environmental markets and related resource efficiency sectors, provided an update of the development of its assets under discretionary and advisory management (AUM) in the first quarter of its financial year. On 31 December 2016 AUM reached a new peak of £5,060 million, representing an increase of 12% over the quarter. "Impax has followed its unprecedented growth during the 2016 financial year with record quarterly inflows into our listed equity funds this quarter, particularly from clients in Continental Europe and North America."
Nichols (LON:NICL) 1592p £587.2m
In line FY Dec16 trading update from the international soft drinks business. Revenue for the year has increased by 7.3% totalling £117.3m. The growth has come from both the UK & International business activities.
UK sales have increased by 6.9% against the prior year to £90.7m (2015: £84.8m). This increase has been driven by sales of the Vimto brand, which were 5% ahead of the prior year, and the incremental revenues from the successful acquisition of The Noisy Drinks Co. Ltd. This performance is significantly ahead of the UK soft drinks market which grew by 0.8% in the year to 3 December 2016. International sales grew by 8.8% to £26.6m. FYDec16E rev £118.5m, EPS of 66.1p.
Focusrite (LON:TUNE) 208.5p £121.1m
AGM statement from the global music and audio products company that trades under the Focusrite and Novation brands around the world. "In November 2016, at the time of our final results announcement, we updated the market that our positive trading momentum had continued since the year end. I am pleased to confirm that November and December also demonstrated good growth in revenue compared with the prior year, coupled with strong cash generation." FY AUG 17E revs of £61.85m and EPS of 12.25p.
Majestic Wines (LON:WINE) 324p £229.3m
Group sales for the 10 week Christmas trading period ending 2 January 2017 increased by 15.3% versus the same period in the prior year. On an underlying basis the increase was 12.4%. The Group delivers c.30% of total annual sales during the Christmas trading period. Majestic Retail had its biggest ever Christmas with like for like sales up 7.5%, on top of 7.3% like for like growth in Christmas last year. Approximately 0.5% of the growth was one-off due to transfer of sales from closed stores. Gross margin down 1% point but profits expected to be in line with expectations. FY Mar17E rev of £445.18m. EPS of 11.88p.
The sports nutrition company that develops, manufactures and markets sports nutrition products for professional athletes and sports enthusiasts, announced it is now the Official Sports Nutrition Supplier to British Cycling, the internationally recognised body for cycling in the UK. The supplier deal will run for four years, effective January 2017, and will see the Company support the Great Britain Cycling Team up to and including the Tokyo 2020 Olympic and Paralympic Games. FYDec16E rev of £12.2m and pre-tax loss of £1.19m